Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs may help treat both COVID-19 and radiation injury.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Some recovered COVID-19 patients experience skin, hair, and nail issues, suggesting they need follow-up care.

Gender-affirming care for youth remained essential during the COVID-19 pandemic, with telemedicine playing a key role.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

The study suggests pandemic stress might worsen or trigger hair loss problems.

Monocytes might be linked to hair loss after COVID-19.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

No significant link between male pattern baldness and COVID-19 severity was found.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

After severe COVID-19, lung damage can improve, detected effectively by lung-ultrasound, and high pressure support during hospitalization can increase lung artery size. Also, about 22% of patients had lung blood clots, and when treated, they recovered faster.

Public interest in hair loss increased during the COVID-19 pandemic.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

COVID-19 vaccines do not increase the risk of alopecia areata.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.

COVID-19 can cause skin issues like rashes and hair loss, which may last even after recovery.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Men with male pattern baldness may be more at risk for severe COVID-19, and anti-androgen treatments could offer protection.

COVID-19 can cause hair loss, loss of taste and smell, skin changes, and eye problems.

Some people who recover from COVID-19 continue to have symptoms like fatigue and cough for over 120 days, and some experience hair loss about 59 days after getting sick.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.